D-097-2013 Class III Terminated

Recalled by Genentech, Inc. — South San Francisco, CA

FDA drug recall D-097-2013 was initiated by Genentech, Inc. on Sep 27, 2012 and is designated Class III. Reason for recall: Short Fill: some bottles contained less than 120-count per labeled claim. The recall status is terminated (terminated Nov 20, 2014). Affected quantity: 1128 bottles.

Recall Details

Product Type
Drugs
Report Date
Dec 26, 2012
Initiation Date
Sep 27, 2012
Termination Date
Nov 20, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1128 bottles

Product Description

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Reason for Recall

Short Fill: some bottles contained less than 120-count per labeled claim.

Distribution Pattern

Nationwide

Code Information

Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-097-2013
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-097-2013. Report a data issue: hello@regdatalab.com.